Concepedia

Author

Jonathan Bard

CHDI FoundationORCID

Also Known As

Bard, Jonathan, J A Bard, J Bard, J. A. Bard, J. Bard, J.A BARD, J.A. Bard, JONATHAN A. BARD, JONATHAN BARD, Jonathan A Bard

97

Publications

5.6K

Citations

34

H-Index

87

Concepts

All Affiliations

CHDI FoundationPrinceton UniversitySynaptic Research (United States)Albany Molecular Research (United States)Pearl River Community College
JB

About

Jonathan Bard is an author at CHDI Foundation specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

32

3K

2

Natural Sciences

12

13

1.2K

3

Health Sciences

3

3

41

4

Social Sciences

2

2

160

5

Engineering

1

1

675

Jonathan Bard

×

54

Publications

5.5K

Citations

34

H-Index

YearCitations

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery

Mei-Chu Lo, Ann Aulabaugh, Guixian Jin,

Analytical Biochemistry

2004

675

Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.

Jonathan Bard, J M Zgombick, Nika Adham,

Journal of Biological Chemistry

1993

526

Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YY

Jonathan Bard, Mary W. Walker, Theresa A. Branchek,

Journal of Biological Chemistry

1995

372

The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Carlos Forray, Jonathan Bard, J. M. WETZEL,

Molecular Pharmacology

1994

349

A receptor autoradiographic and <i>in situ</i> hybridization analysis of the distribution of the 5‐ht<sub>7</sub> receptor in rat brain

Eric L. Gustafson, Margaret M. Durkin, Jonathan Bard,

British Journal of Pharmacology

1996

291

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.

Nika Adham, Hung‐Teh Kao, L E Schecter,

Proceedings of the National Academy of Sciences

1993

286

Cloned Human and Rat Galanin GALR3 Receptors

Kelli E. Smith, Mary W. Walker, Roman Artymyshyn,

Journal of Biological Chemistry

1998

257

The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

Christophe Gerald, Nika Adham, Hung‐Teh Kao,

The EMBO Journal

1995

245

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

Bryan Zeitler, Steven Froelich, Kimberly Marlen,

Nature Medicine

2019

212

Expression Cloning of a Rat Hypothalamic Galanin Receptor Coupled to Phosphoinositide Turnover

Kelli E. Smith, Carlos Forray, Mary W. Walker,

Journal of Biological Chemistry

1997

193

Page 1